We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon
Read MoreHide Full Article
SenesTech, Inc. (SNES - Free Report) , a player in the field of fertility control for managing animal pest populations, has announced the launch of its Evolve fertility control solution for rats on Amazon (AMZN - Free Report) . This strategic move marks a significant advancement in the distribution of Evolve, the company's innovative minimum-risk soft bait designed for proactive rat control.
More on Evolve
Unlike traditional methods that rely heavily on poisons, Evolve targets the root cause of rodent overpopulation by reducing fertility rates.
This approach addresses the rapid reproduction of rodents, which can lead to severe infestations. The active ingredient in Evolve has been scientifically proven to reduce rodent fertility, making it a safer and more effective alternative to conventional poisons.
Accessibility and Market Growth
The launch on Amazon, the world's largest online retailer, significantly enhances the accessibility of Evolve to everyday consumers. The product was previously available primarily to professionals. Evolve's presence on Amazon allows a broader audience to adopt this effective pest control solution.
This move is expected to drive substantial growth in SenesTech’s market share, leveraging the convenience and reach of e-commerce.
Image Source: Zacks Investment Research
Adapting to Regulatory Changes
With increasing regulations on the use of traditional rodenticides, particularly in states like California, consumers and pest managers are actively seeking safer and more sustainable alternatives. Evolve’s availability on Amazon is well-timed, providing a viable solution that complies with stricter regulatory standards while maintaining efficacy in pest management.
Market Prospects
Per SenesTech, the U.S. rodent pest management market is valued at more than $1 billion annually, with a significant portion of sales occurring online. By tapping into this growing e-commerce segment, SenesTech is well-positioned to capitalize on the increasing demand for innovative pest control solutions. The strategic placement of Evolve on Amazon is expected to drive sustained growth for SenesTech.
Share Price Performance
Year to date, shares of SNES have plunged 42.5% against the industry’s 2.6% growth.
Zacks Rank and Key Picks
Senestech currently carries a Zacks Rank #4 (Sell).
Hims & Hers Heath stock has rallied 119.1% in the past year. Earnings estimates for the company have risen from 11 cents to 18 cents for 2024 and from 25 cents to 33 cents for 2025 in the past 30 days.
HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.
Estimates for Medpace’s 2024 earnings per share have moved up to $11.29 from $11.23 in the past 30 days. Shares of the company have surged 87.5% in the past year compared with the industry’s 6.1% growth.
MEDP’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 12.8%. In the last reported quarter, it delivered an average earnings surprise of 30.6%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon
SenesTech, Inc. (SNES - Free Report) , a player in the field of fertility control for managing animal pest populations, has announced the launch of its Evolve fertility control solution for rats on Amazon (AMZN - Free Report) . This strategic move marks a significant advancement in the distribution of Evolve, the company's innovative minimum-risk soft bait designed for proactive rat control.
More on Evolve
Unlike traditional methods that rely heavily on poisons, Evolve targets the root cause of rodent overpopulation by reducing fertility rates.
This approach addresses the rapid reproduction of rodents, which can lead to severe infestations. The active ingredient in Evolve has been scientifically proven to reduce rodent fertility, making it a safer and more effective alternative to conventional poisons.
Accessibility and Market Growth
The launch on Amazon, the world's largest online retailer, significantly enhances the accessibility of Evolve to everyday consumers. The product was previously available primarily to professionals. Evolve's presence on Amazon allows a broader audience to adopt this effective pest control solution.
This move is expected to drive substantial growth in SenesTech’s market share, leveraging the convenience and reach of e-commerce.
Image Source: Zacks Investment Research
Adapting to Regulatory Changes
With increasing regulations on the use of traditional rodenticides, particularly in states like California, consumers and pest managers are actively seeking safer and more sustainable alternatives. Evolve’s availability on Amazon is well-timed, providing a viable solution that complies with stricter regulatory standards while maintaining efficacy in pest management.
Market Prospects
Per SenesTech, the U.S. rodent pest management market is valued at more than $1 billion annually, with a significant portion of sales occurring online. By tapping into this growing e-commerce segment, SenesTech is well-positioned to capitalize on the increasing demand for innovative pest control solutions. The strategic placement of Evolve on Amazon is expected to drive sustained growth for SenesTech.
Share Price Performance
Year to date, shares of SNES have plunged 42.5% against the industry’s 2.6% growth.
Zacks Rank and Key Picks
Senestech currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader medical space are Hims & Hers Health (HIMS - Free Report) and Medpace (MEDP - Free Report) . Each of them sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks Rank #1 stocks here.
Hims & Hers Heath stock has rallied 119.1% in the past year. Earnings estimates for the company have risen from 11 cents to 18 cents for 2024 and from 25 cents to 33 cents for 2025 in the past 30 days.
HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.
Estimates for Medpace’s 2024 earnings per share have moved up to $11.29 from $11.23 in the past 30 days. Shares of the company have surged 87.5% in the past year compared with the industry’s 6.1% growth.
MEDP’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 12.8%. In the last reported quarter, it delivered an average earnings surprise of 30.6%.